Published in Hepatitis Weekly, January 2nd, 2006
The only two treatments available for CDAD in the United States are metronidazole and vancomycin. Metronidazole has been the standard of care for CDAD, but the rate of response to metronidazole is reported to have declined significantly in recent years. Vancomycin is typically reserved because of its cost and the risk of selecting vancomycin-resistant bacteria.
Romark recently completed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly